1. MARKETS
  2. SECTOR : HARDWARE TECHNOLOGY & EQUIPMENT
  3. INDUSTRY : SEMICONDUCTORS
  4. ASTERA LABS INC.
Astera Labs Inc.
XNAS: ALAB
382.25-7.55(-1.94%)
5.0M
XNAS Volume

XNAS 07 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Astera Labs Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Astera Labs Inc share price target, revenues, EPS, net income and more

Astera Labs Inc quarterly results: revenue, profit, and P&L – 13 quarter history

  • POSITIVE

    Quarterly Revenue Astera Labs Inc Jun-2026 Quarterly Revenue is $392 Million which is growth of 104.5% YoY.

  • POSITIVE

    Quarterly Net Profit Astera Labs Inc Jun-2026 Quarterly Net Profit is $153 Million which is growth of 198.9% YoY.

Astera Labs Inc., Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
392.4308.4270.6230.6191.9159.4141.1113.176.965.350.536.910.7
Cost Of Rev.
104.873.266.154.846.44036.725.21714.711.58.82.3
Gross Profit
287.6235.1204.5175.8145.6119.4104.587.959.950.53928.18.4
⌄
198.3173.3137.5120.4105.8108.1104.396.884.2133.53030.126.1
Operating Profit
89.361.86755.439.811.30.1-8.9-24.4-839-2-17.6
13.611.61211.510.910.410.610.910.32.61.71.71.6
Profit Before Tax
102.873.478.966.950.721.710.72-14.1-80.410.7-0.3-16.1
Tax
-50.3-6.933.9-24.3-0.6-10.1-149.6-6.512.6-3.62.94
⌄
153.180.34591.151.231.824.7-7.6-7.6-9314.3-3.1-20
Diluted NI Avail to Com Stockholders Ann.
153.180.34591.151.231.824.7-7.6-7.6-9314.3-3.1-20
Basic EPS
0.90.50.30.50.30.20.2-0.1-0.1-1.80.1-0-0.2
Diluted EPS After ExtraOrdinary
0.80.40.30.50.30.20.1-0.1-0.1-1.80.1-0-0.2
Number Of Shares End
172.4170.7169.5167.4165.4163.2160.1156.8155.252.5152.5152.5130.5
Net Income Continuing Discontinued Operations
153.180.34591.151.231.824.7-7.6-7.6-9314.3-3.1-20
Normalized Income
153.180.34591.151.231.824.7-7.6-7.6-9314.3-3.1-20
Interest Income
13.611.61211.510.910.410.610.910.32.61.71.71.6
Interest
-------------
Net Interest Income
13.611.61211.510.910.410.610.910.32.61.71.71.6
EBIT
89.361.86755.439.811.30.1-8.9-24.4-839-2-17.6
EBITDA
93.265.569.856.941.212.41.1-8.1-23.6-82.49.6-1.5-17.2
Reconciled Cost Of Rev.
104.873.266.154.846.44036.725.21714.711.58.82.3
Reconciled Depr.
3.93.72.91.51.41.110.90.70.60.50.50.4
Profit From Continuing Operations
153.180.34591.151.231.824.7-7.6-7.6-9314.3-3.1-20
Normalized EBITDA
93.265.569.856.941.212.41.1-8.1-23.6-82.49.6-1.5-17.2
*All financials are in USD Million and price data in USD

Astera Labs Inc competitor comparison and performance snapshot within industry

Astera Labs Inc annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

  • POSITIVE

    Annual Revenue Astera Labs Inc Dec-2025 Annual Revenue is $853 Million which is growth of 115.1% YoY.

  • POSITIVE

    Annual Net Profit Astera Labs Inc Dec-2025 Annual Net Profit is $219 Million which is growth of 362.7% YoY.

Astera Labs Inc., Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsTTMDec '25Dec '24Dec '23Dec '22
120.1%
 852.5396.3115.879.9
Cost Of Rev. Ann.
113.8%
298.9207.393.63621.2
Gross Profit Ann.
122.4%
903645.3302.779.858.7
Operating Exp. Ann.
58.3%
629.6471.8418.8109.3118.9
Operating Profit Ann.
-
273.4173.4-116.1-29.5-60.2
158.1%
48.644.734.36.62.6
Other Exp. Ann.
-
 ----
PBT Ann.
-
322218.2-81.8-23-57.6
Tax Ann.
-
-47.5-11.63.30.8
⌄
-
369.5219.1-83.4-26.3-58.3
Diluted NI Avail to Com Stockholders Ann.
-
369.5219.1-83.4-26.3-58.3
EPS Ann.
-
 1.3-0.6-0.2-0.5
Diluted EPS Ann.
-
 1.2-0.6-0.2-0.5
Number Of Shares End
-
 169.5160.1152.5-
Total Exp. Ann.
69.2%
 679.1512.4145.3140.1
Net Income Continuing Discontinued Operations Ann.
-
369.5219.1-83.4-26.3-58.3
Normalized Income Ann.
-
369.5219.1-83.4-26.3-58.3
Interest Income Ann.
158.1%
48.644.734.36.62.6
Interest Ann.
-
 ----
EBITDA Ann.
-
285.4180.3-112.9-27.7-59.4
Reconciled Cost Of Rev. Ann.
113.8%
298.9207.393.63621.2
Reconciled Depr. Ann.
104.1%
126.83.21.80.8
Profit From Continuing Operations Ann.
-
369.5219.1-83.4-26.3-58.3
Normalized EBITDA Ann.
-
285.4180.3-112.9-27.7-59.4
*All financials are in USD Million and price data in USD
Total Rev. Ann.
1Y CHG
115.1%
2Y CAGR
171.3%
3Y CAGR
120.1%
Operating Exp. Ann.
1Y CHG
12.7%
2Y CAGR
107.8%
3Y CAGR
58.3%

Astera Labs Inc balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

  • POSITIVE

    Total Shareholders Fund Astera Labs Inc Dec-2025 Total Shareholders Fund is $1,364 Million which is growth of 41.3% YoY.

  • POSITIVE

    Total Assets Astera Labs Inc Dec-2025 Total Assets is $1,532 Million which is growth of 45.3% YoY.

Astera Labs Inc., Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsDec '25Dec '24Dec '23Dec '22
93.4%
1,531.81,054.5196.3211.7
⌄
-17.3%
168.289.7294297
⌄
-
1,363.6964.8-97.7-85.3
Total Capitalization Ann.
-
1,363.6964.8-97.7-85.3
Tangible Assets Ann.
-
1,363.6964.8-97.7-85.3
Working Capital Ann.
94.9%
1,229926.4150.7165.9
Invested Capital Ann.
-
1,363.6964.8-97.7-85.3
Tangible Book Value Ann.
-
1,363.6964.8-97.7-85.3
Borrowings Ann.
37.9%
4.21.32.21.6
Net Debt Ann.
-
----
Share Issued Ann.
3.7%
170.2162152.5152.5
Number Of Shares End
-
169.5160.1152.5-
*All financials are in USD Million and price data in USD
Total Assets Ann.
1Y CHG
45.3%
2Y CAGR
179.3%
3Y CAGR
93.4%
Total Current Liabilities Ann.
1Y CHG
53.8%
2Y CAGR
94.7%
3Y CAGR
49.1%
Total ShareHolders Funds Ann.
1Y CHG
41.3%

Astera Labs Inc ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

  • POSITIVE

    Book Value Per Share Astera Labs Inc Book Value Per Share is $10 which is growth of 45.6% YoY.

  • NEUTRAL

    ROE Astera Labs Inc ROE is 0% which is growth of 0% YoY.

Astera Labs Inc., Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsDec '25Dec '24Dec '23Dec '22
RoA Ann. %
-
--13.34%-12.87%-27.56%
ROE Ann. %
-
--19.24%--
ROIC %
-
-1.8--
OPM Ann. %
-
20.34%-29.29%-25.47%-75.36%
Inventory Turnover Ratio Ann.
-
-2.81.40.7
Asset Turnover Ann. %
-
-0.60.60.4
Working Capital Turnover Ann.
11.9%
0.70.40.80.5
Quick Ratio Ann.
-
-114.54.3
Current Ratio Ann.
-
-11.75.35.1
Interest Coverage Ratio Ann.
-
----
LT Debt To Equity Ann.
-
----
*All financials are in USD Million and price data in USD

Astera Labs Inc cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

  • POSITIVE

    Cash From Operating Activity Astera Labs Inc Dec-2025 Cash From Operating Activity is $319 Million which is growth of 133.6% YoY.

  • POSITIVE

    Net Cash Flow Astera Labs Inc Dec-2025 Net Cash Flow is $88 Million which is growth of 150.8% YoY.

Astera Labs Inc., Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsDec '25Dec '24Dec '23Dec '22
-
319.3136.7-12.7-35.9
-
-241.5-757.6-17.8-90.6
-59.9%
9.8655.8-0.5151.7
Cash Plus Cash Eqv. End Of Year Ann.
30.1%
167.78045.176.1
Net Increase In Cash Plus Cash Eqv.s Ann.
51.5%
87.635-3125.2
Cash Plus Cash Eqv. Begin Of Year Ann.
16.3%
8045.176.150.9
Income Tax Paid Supplemental Data Ann.
-
1.67.82.5
Interest Paid Supplemental Data Ann.
-
----
Capex Ann.
-
-37.5-34.2-2.8-3.9
Issuance Of Capital Stock Ann.
-
672.2149.9
Issuance Of Debt Ann.
-
----
Repayment Of Debt Ann.
-
----
Repurchase Of Capital Stock Ann.
-
-1.1-0.2-0.3
Free Cash Flow Ann.
-
281.8102.4-15.5-39.8
*All financials are in USD Million and price data in USD
Cash from Operating Act. Ann.
1Y CHG
133.6%
Cash from Financing Act. Ann.
1Y CHG
-98.5%
3Y CAGR
-59.9%